You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR MINIPRESS


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Minipress

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00161473 ↗ Alzheimer's in Long-Term Care--Treatment for Agitation Completed National Institute on Aging (NIA) N/A 2001-01-01 The purpose of this study is to see if a medication called prazosin is useful in the treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other types of dementia in late life.
NCT00161473 ↗ Alzheimer's in Long-Term Care--Treatment for Agitation Completed University of Washington N/A 2001-01-01 The purpose of this study is to see if a medication called prazosin is useful in the treatment of agitation and aggression in persons with Alzheimer's disease (AD) and other types of dementia in late life.
NCT00175682 ↗ Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study Completed University of British Columbia N/A 2004-12-01 Sexuality is a high rehabilitative priority for persons following a spinal cord injury (SCI). Sexual acts can lead to autonomic dysreflexia (AD), dangerous consequences such as a sudden increase in blood pressure, severe headache, sweating above the level of the lesion and low heart rate to name a few. Ejaculation in men can provoke these significant symptoms and therefore men and women may refrain from a sexual life and biological parenthood. Adalat is the most common antihypertensive used in fertility clinics to reduce the incidence of AD. It dramatically reduces blood pressure and, therefore, results in side effects such as dizziness, fatigue and weakness. The investigators hypothesize that Minipress® (prazosin HCL), a blood pressure medication, which has a slower and less abrupt suppressive effect on blood pressure, would be a safe, effective and more appropriate medication for use in the outpatient sperm retrieval clinic and potentially for private use.
NCT00183430 ↗ Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder Terminated National Institute of Mental Health (NIMH) N/A 2003-10-01 This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.
NCT00183430 ↗ Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder Terminated Seattle Institute for Biomedical and Clinical Research N/A 2003-10-01 This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.
NCT00202449 ↗ Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance Terminated United States Department of Defense N/A 2004-07-01 The purposes of this study are: - to evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF). - to evaluate the effects of the selective serotonin reuptake inhibitor (SSRI) paroxetine on behavioral symptoms and overall function in this population.
NCT00202449 ↗ Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance Terminated VA Puget Sound Health Care System N/A 2004-07-01 The purposes of this study are: - to evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF). - to evaluate the effects of the selective serotonin reuptake inhibitor (SSRI) paroxetine on behavioral symptoms and overall function in this population.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Minipress

Condition Name

Condition Name for Minipress
Intervention Trials
Posttraumatic Stress Disorder 5
Hypertension 2
Stress Disorders, Post-Traumatic 2
Alzheimer's Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Minipress
Intervention Trials
Stress Disorders, Post-Traumatic 9
Disease 7
Stress Disorders, Traumatic 7
Alcoholism 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Minipress

Trials by Country

Trials by Country for Minipress
Location Trials
United States 32
Canada 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Minipress
Location Trials
Washington 14
Connecticut 3
California 2
Maryland 1
Colorado 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Minipress

Clinical Trial Phase

Clinical Trial Phase for Minipress
Clinical Trial Phase Trials
Phase 4 4
Phase 3 2
Phase 2 7
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Minipress
Clinical Trial Phase Trials
Completed 13
Recruiting 7
Withdrawn 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Minipress

Sponsor Name

Sponsor Name for Minipress
Sponsor Trials
Seattle Institute for Biomedical and Clinical Research 7
VA Puget Sound Health Care System 7
VA Office of Research and Development 4
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Minipress
Sponsor Trials
Other 29
U.S. Fed 15
NIH 8
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.